<DOC>
	<DOCNO>NCT02969096</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy target cryoablation therapy hepatic carcinoma .</brief_summary>
	<brief_title>Clinical Study Targeted Cryoablation Therapy Treatment Hepatic Carcinoma</brief_title>
	<detailed_description>A cryoprobe insert percutaneously CT guidance target lesion . Patients undergo ablation use freeze-thaw-freeze cycle last approximately 10-6-10minutes .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Diagnosis liver cancer base histology current accept radiological measure . Single Tumor size ≤5.0 cm great diameter , multiple tumor number≤3 tumor size≤ 3cm . Life expectancy : Greater 3 month . Patients ' liver function Childpugh A B . Ability understand study protocol willingness sign write informed consent document . Unable receive operative surgery . Patients primary tumor except liver cancer . History coagulation disorder anemia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>